Peer-reviewedCC BYCureus
Zileuton Beyond Asthma: A Multifaceted 5-Lipoxygenase Inhibitor With Emerging Therapeutic Potential Across Inflammation, Cancer, Neuroprotection, and Fibrosis
- 1School of Medicine, Lake Erie College of Osteopathic Medicine, Erie, USA
- 2Pediatrics, East Carolina University, Greenville, USA
Related
- Photothrombotic Ischemic Stroke in Rats: A Systematic Review of Experimental Parameters and Therapeutic Applications in Neuroprotection, Neuromodulation, and Post-Stroke Recovery
- Multifaceted Impact of MicroRNA 493-5p on Genome-Stabilizing Pathways Induces Platinum and PARP Inhibitor Resistance in BRCA2-Mutated Carcinomas
- Cancer-associated fibroblasts: multifaceted regulators of the tumor microenvironment and emerging therapeutic targets
- Discovery of a potent covalent inhibitor for the treatment of sepsis targeting DNAJC9: Identification of a druggable target for inflammation.
- Perspectives on Bempedoic Acid, ATP-citrate lyase inhibitor: Targeting Lipid Metabolism and Inflammation
BibTeX
@article{ivancev2026zileuton,
title = {{Zileuton Beyond Asthma: A Multifaceted 5-Lipoxygenase Inhibitor With Emerging Therapeutic Potential Across Inflammation, Cancer, Neuroprotection, and Fibrosis}},
author = {Victor D Ivancev and Joshua Iskander and Julia Hanna and Kiran Ghotra and Clark Iorio and Diana V Ivancev},
journal = {Cureus},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13675071},
note = {CC BY},
}
RIS
TY - JOUR
TI - Zileuton Beyond Asthma: A Multifaceted 5-Lipoxygenase Inhibitor With Emerging Therapeutic Potential Across Inflammation, Cancer, Neuroprotection, and Fibrosis
AU - Victor D Ivancev
AU - Joshua Iskander
AU - Julia Hanna
AU - Kiran Ghotra
AU - Clark Iorio
AU - Diana V Ivancev
PY - 2026
DA - 2026/10/19
JO - Cureus
UR - https://europepmc.org/article/PMC/PMC13675071
SN - 2168-8184
ER -